{"id":"https://openalex.org/W2015182670","doi":"https://doi.org/10.1159/000151639","title":"The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator","display_name":"The JNK Inhibitor XG-102 Protects from Ischemic Damage with Delayed Intravenous Administration Also in the Presence of Recombinant Tissue Plasminogen Activator","alternate_titles":[],"publication_year":2008,"publication_date":"2008-08-27","ids":{"openalex":"https://openalex.org/W2015182670","doi":"https://doi.org/10.1159/000151639","mag":"2015182670","pmid":"https://pubmed.ncbi.nlm.nih.gov/18728363"},"language":"en","primary_location":{"id":"doi:10.1159/000151639","doi":"https://doi.org/10.1159/000151639","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000151639","pdf_url":null,"source":{"id":"https://openalex.org/S43436036","display_name":"Cerebrovascular Diseases","issn_l":"1015-9770","issn":["1015-9770","1421-9786"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cerebrovascular Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015182670"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029283193","display_name":"Karine Wiegler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karine Wiegler","raw_affiliation_strings":["Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse","Service de Neurologie et"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Neurologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Suisse","institution_ids":["https://openalex.org/I2802229882"]},{"raw_affiliation_string":"Service de Neurologie et","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002023781","display_name":"Christophe Bonny","orcid":"https://orcid.org/0009-0006-8890-0290","observed_orcids":["https://orcid.org/0009-0006-8890-0290"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]},{"id":"https://openalex.org/I4210118029","display_name":"Xigen (Switzerland)","ror":"https://ror.org/027f5z015","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210118029"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christophe Bonny","raw_affiliation_strings":["Service de G\u00e9n\u00e9tique m\u00e9dicale, Centre Hospitalier Universitaire Vaudois, et","Xigen Pharmaceuticals, Lausanne, Suisse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de G\u00e9n\u00e9tique m\u00e9dicale, Centre Hospitalier Universitaire Vaudois, et","institution_ids":["https://openalex.org/I2802229882"]},{"raw_affiliation_string":"Xigen Pharmaceuticals, Lausanne, Suisse","institution_ids":["https://openalex.org/I4210118029"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023894275","display_name":"Didier Coquoz","orcid":"https://orcid.org/0000-0001-8270-3831","observed_orcids":["https://orcid.org/0000-0001-8270-3831"]},"institutions":[{"id":"https://openalex.org/I4210118029","display_name":"Xigen (Switzerland)","ror":"https://ror.org/027f5z015","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210118029"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Didier Coquoz","raw_affiliation_strings":["Xigen Pharmaceuticals, Lausanne, Suisse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xigen Pharmaceuticals, Lausanne, Suisse","institution_ids":["https://openalex.org/I4210118029"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084034589","display_name":"Lorenz Hirt","orcid":"https://orcid.org/0000-0002-2921-5000","observed_orcids":["https://orcid.org/0000-0002-2921-5000"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lorenz Hirt","raw_affiliation_strings":["Service de Neurologie et"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Neurologie et","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.2724,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.94180882,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"26","issue":"4","first_page":"360","last_page":"366"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.7583000063896179,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.21629999577999115,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-jun-n-terminal-kinase-inhibitor","display_name":"c-Jun N-terminal kinase inhibitor","score":0.925000011920929},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7910000085830688},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.9290000200271606},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9380000233650208},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8849999904632568},{"id":"https://openalex.org/keywords/alteplase","display_name":"alteplase","score":0.9639999866485596},{"id":"https://openalex.org/keywords/intravenous-thrombolysis","display_name":"intravenous thrombolysis","score":0.9559999704360962},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.9509999752044678},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.8840000033378601},{"id":"https://openalex.org/keywords/oxygen-glucose-deprivation","display_name":"oxygen-glucose deprivation","score":0.7120000123977661},{"id":"https://openalex.org/keywords/hippocampal-slice-cultures","display_name":"hippocampal slice cultures","score":0.6809999942779541},{"id":"https://openalex.org/keywords/delayed-drug-administration","display_name":"delayed drug administration","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8311256766319275},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8005639910697937},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.6605319380760193},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5716262459754944},{"id":"https://openalex.org/C2779581417","wikidata":"https://www.wikidata.org/wiki/Q1931577","display_name":"Thrombolysis","level":3,"score":0.5533344149589539},{"id":"https://openalex.org/C2776572282","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"Tissue plasminogen activator","level":2,"score":0.527046263217926},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5136682391166687},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.4607667922973633},{"id":"https://openalex.org/C2781012912","wikidata":"https://www.wikidata.org/wiki/Q901117","display_name":"Excitotoxicity","level":4,"score":0.4552255868911743},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4517776072025299},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25502917170524597},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.1550227403640747},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1199674904346466},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.09886413812637329},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07754850387573242},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006624","descriptor_name":"Hippocampus","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009924","descriptor_name":"Organ Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D020244","descriptor_name":"Infarction, Middle Cerebral Artery","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D048031","descriptor_name":"JNK Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1159/000151639","doi":"https://doi.org/10.1159/000151639","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000151639","pdf_url":null,"source":{"id":"https://openalex.org/S43436036","display_name":"Cerebrovascular Diseases","issn_l":"1015-9770","issn":["1015-9770","1421-9786"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cerebrovascular Diseases","raw_type":"journal-article"},{"id":"pmid:18728363","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18728363","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cerebrovascular diseases (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unil.ch:iris/257820","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/257820","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"journal article"},{"id":"pmh:oai:serval.unil.ch:BIB_ECDCF3346035","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_ECDCF3346035","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cerebrovascular Diseases (basel, Switzerland), vol. 26, no. 4, pp. 360-366","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1530284699","https://openalex.org/W1976235475","https://openalex.org/W1984801123","https://openalex.org/W2005509576","https://openalex.org/W2007943920","https://openalex.org/W2009191140","https://openalex.org/W2013662783","https://openalex.org/W2019214426","https://openalex.org/W2044671618","https://openalex.org/W2046523597","https://openalex.org/W2054998458","https://openalex.org/W2059995799","https://openalex.org/W2086507786","https://openalex.org/W2135637406","https://openalex.org/W2135951997","https://openalex.org/W2136280619","https://openalex.org/W2149789552","https://openalex.org/W2156488055","https://openalex.org/W2160038308","https://openalex.org/W2160974829","https://openalex.org/W2292308933"],"related_works":["https://openalex.org/W7011751284","https://openalex.org/W2028557994","https://openalex.org/W3012788525","https://openalex.org/W2604688338","https://openalex.org/W2036426144","https://openalex.org/W4392375495","https://openalex.org/W2160038308","https://openalex.org/W2041158332","https://openalex.org/W1980075091","https://openalex.org/W2425666840"],"abstract_inverted_index":{"BACKGROUND:":[0],"XG-102":[1,94,129,204,219,228],"(formerly":[2],"D-JNKI1),":[3],"a":[4,16,50,91,99,210,225,259],"TAT-coupled":[5],"dextrogyre":[6],"peptide":[7],"which":[8,48,147],"selectively":[9],"inhibits":[10],"the":[11,63,66,149,164,194,234],"c-Jun":[12],"N-terminal":[13],"kinase,":[14],"is":[15,49],"powerful":[17,226],"neuroprotectant":[18],"in":[19,57,98,132,135,198,201,233,262],"mouse":[20],"models":[21],"of":[22,46,65,189,218,236,240,243],"middle":[23],"cerebral":[24],"artery":[25],"occlusion":[26],"(MCAo)":[27],"with":[28,68,250],"delayed":[29],"intracerebroventricular":[30],"injection.":[31],"We":[32,60],"aimed":[33],"to":[34,81,90,111,167,208],"determine":[35],"whether":[36],"this":[37,244],"neuroprotection":[38,143],"could":[39],"also":[40,61,182],"be":[41],"achieved":[42],"by":[43],"intravenous":[44,77,140,216],"injection":[45],"XG-102,":[47],"more":[51],"feasible":[52],"approach":[53],"for":[54,76,119,163,255],"future":[55],"use":[56],"stroke":[58],"patients.":[59],"tested":[62],"compatibility":[64,249],"compound":[67,246],"recombinant":[69],"tissue":[70],"plasminogen":[71],"activator":[72],"(rtPA),":[73],"commonly":[74],"used":[75],"thrombolysis":[78],"and":[79,114,127,134,200,247],"known":[80],"enhance":[82],"excitotoxicity.":[83],"METHODS:":[84],"Male":[85],"ICR-CD1":[86],"mice":[87],"were":[88,109],"subjected":[89,110],"30-min-suture":[92],"MCAo.":[93],"was":[95,123,144,181,205],"injected":[96],"intravenously":[97],"single":[100,215],"dose,":[101],"6":[102],"h":[103,154],"after":[104,125,152,191,222],"ischemia.":[105],"Hippocampal":[106],"slice":[107],"cultures":[108],"oxygen":[112],"(5%)":[113],"glucose":[115],"(1":[116],"mM)":[117],"deprivation":[118],"30":[120],"min.":[121],"rtPA":[122,190,251],"added":[124],"ischemia":[126,192,223],"before":[128],"administration,":[130],"both":[131,197],"vitro":[133,199],"vivo.":[136],"RESULTS:":[137],"The":[138,178,238],"lowest":[139],"dose":[141],"achieving":[142],"0.0003":[145],"mg/kg,":[146],"reduced":[148],"infarct":[150],"volume":[151],"48":[153],"from":[155,230],"62":[156],"+/-":[157,169],"19":[158],"mm(3)":[159,171],"(n":[160,172],"=":[161,173],"18)":[162],"vehicle-treated":[165],"group":[166],"18":[168],"9":[170],"5,":[174],"p":[175],"<":[176],"0.01).":[177],"behavioral":[179],"outcome":[180],"significantly":[183],"improved":[184],"at":[185],"two":[186],"doses.":[187],"Addition":[188],"enhanced":[193],"ischemic":[195,231,263],"damage":[196,232],"vivo,":[202],"but":[203],"still":[206],"able":[207],"induce":[209],"significant":[211],"neuroprotection.":[212,227],"CONCLUSIONS:":[213],"A":[214],"administration":[217,242],"several":[220],"hours":[221],"induces":[224],"protects":[229],"presence":[235],"rtPA.":[237],"feasibility":[239],"systemic":[241],"promising":[245],"its":[248,256],"are":[252],"important":[253],"steps":[254],"development":[257],"as":[258],"drug":[260],"candidate":[261],"stroke.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015182670","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
